Published in Catheter Cardiovasc Interv on December 01, 2006
Left ventricular to right atrial shunt (Gerbode defect): congenital versus acquired. Postepy Kardiol Interwencyjnej (2014) 1.03
Transcatheter closure of acquired left ventricle-to-right atrium shunt: first case report in an infant and review of the literature. Pediatr Cardiol (2012) 0.93
Gerbode defect: Another nail for the 3D transesophagel echo hammer? Int J Cardiovasc Imaging (2015) 0.87
Percutaneous closure of the acquired gerbode shunt using the amplatzer duct occluder in a 3-month old patient. Korean Circ J (2013) 0.79
Acquired left ventricle-to-right atrium shunt: clinical implications and diagnostic dilemmas. Wien Klin Wochenschr (2015) 0.78
Uncommon acquired Gerbode defect following extensive bicuspid aortic valve endocarditis. Cardiovasc Ultrasound (2012) 0.76
Gerbode Defect of Congenital Variety in an Infant: A Case Report. J Clin Diagn Res (2016) 0.75
Percutaneous Closure of 2 Paravalvular Leaks and a Gerbode Defect after Mitral Valve Replacement for Infective Endocarditis. Tex Heart Inst J (2017) 0.75
Gerbode defect: A comprehensive review of its history, anatomy, embryology, pathophysiology, diagnosis, and treatment. J Saudi Heart Assoc (2017) 0.75
Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (1997) 2.20
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res (1999) 1.91
Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res (2000) 1.67
Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients? Clin Oncol (R Coll Radiol) (2010) 1.60
Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res (1994) 1.59
Intermediate-term results of percutaneous transvenous mitral commissurotomy in children less than 12 years of age. Catheter Cardiovasc Interv (2005) 1.53
MRI features of tuberculoma of the right atrial myocardium. Pediatr Radiol (2004) 1.52
Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Clin Chem (1975) 1.49
Cardiac amyloidosis--an update. Indian Heart J (2004) 1.47
Drug therapy of cardiac diseases in children. Indian Pediatr (2009) 1.46
Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs. J Assoc Physicians India (1991) 1.39
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res (2000) 1.34
Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A (1976) 1.33
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis (1999) 1.31
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer (1994) 1.24
Eales disease--an update. Surv Ophthalmol (2002) 1.15
A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res (1994) 1.14
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett (1997) 1.13
Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res (1995) 1.10
Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer (1993) 1.08
Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye (Lond) (2006) 1.07
Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J Cell Mol Med (2009) 1.07
A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor. Exp Cell Res (1997) 1.07
Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina (2005) 1.07
Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine. Science (1984) 1.06
Antifertility effect of Ocimum sanctum L. Indian J Exp Biol (1972) 1.04
Saccharomyces cerevisiae cells secreting an Aspergillus niger beta-galactosidase grow on whey permeate. Biotechnology (N Y) (1992) 1.03
Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation (2006) 1.03
Telomerase activity in normal human endothelial cells. Anticancer Res (1997) 0.99
Infective endocarditis--an Indian perspective. Indian Heart J (2005) 0.99
Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol (2001) 0.98
Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Cancer Res (1984) 0.97
Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination. Cancer Res (2007) 0.94
Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. Cancer Res (1984) 0.94
Carboplatin selectively induces the VEGF stress response in endothelial cells: Potentiation of antitumor activity by combination treatment with antibody to VEGF. Int J Cancer (2004) 0.93
A learning-enabled neuron array IC based upon transistor channel models of biological phenomena. IEEE Trans Biomed Circuits Syst (2013) 0.93
Neural dynamics in reconfigurable silicon. IEEE Trans Biomed Circuits Syst (2010) 0.93
Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun (1995) 0.92
Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein. Cancer Res (1985) 0.91
Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood. Cancer Res (1985) 0.91
Progressive systemic sclerosis in south India. J Assoc Physicians India (1991) 0.91
Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery. Breast (2010) 0.90
Small-molecule-induced folding of a synthetic polymer. Angew Chem Int Ed Engl (2005) 0.90
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System. Mol Cancer (2011) 0.89
Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int J Cancer (1997) 0.89
Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. Cancer Res (1992) 0.89
Slime production is essential for the adherence of Staphylococcus epidermidis in implant-related infections. J Hosp Infect (2011) 0.89
Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation. J Immunol (1985) 0.89
Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol (1991) 0.88
Floating gate synapses with spike-time-dependent plasticity. IEEE Trans Biomed Circuits Syst (2011) 0.87
Determination of critical micelle concentration by hyper-rayleigh scattering. J Am Chem Soc (2003) 0.87
Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1991) 0.87
Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model. Cancer Res (2000) 0.87
In vivo neutralization of vascular endothelial growth factor (VEGF) vascular permeability factor (VPF) inhibits ovarian carcinoma-associated ascites formation and tumor growth. Int J Oncol (1996) 0.86
Wegener's granulomatosis mimicking prosthetic valve endocarditis. Cardiology (2004) 0.86
Seasonal variations in different forms of pokeweed antiviral protein, a potent inactivator of ribosomes. J Biol Chem (1983) 0.86
Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells. J Immunol (1998) 0.86
Differential effects of opioids on the proliferation of a macrophage cell line, Bac 1.2F5. Cell Immunol (1996) 0.86
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp Cell Res (1993) 0.85
Analysis of breast thermograms using Gabor wavelet anisotropy index. J Med Syst (2014) 0.85
Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer. Gene Ther (2010) 0.85
Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer. Gynecol Obstet Invest (1999) 0.85
Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal fluid macrophage content. Blood (1991) 0.85
Intraperitoneal bladder rupture mimicking acute renal failure. Indian J Nephrol (2008) 0.84
Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene. Hum Gene Ther (2002) 0.84
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol (1991) 0.84
Improved biological activity of a mutant endostatin containing a single amino-acid substitution. Br J Cancer (2004) 0.84
A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee. Osteoarthritis Cartilage (2002) 0.84
Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies. Biochim Biophys Acta (1995) 0.84
Element density and the efficiency of binocular matching. J Opt Soc Am A Opt Image Sci Vis (1997) 0.83
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer. Am J Obstet Gynecol (1996) 0.83
Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth. Int J Cancer (2004) 0.83
AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer. Gene Ther (2010) 0.83
Aromatic donor-acceptor charge-transfer and metal-ion-complexation-assisted folding of a synthetic polymer. Angew Chem Int Ed Engl (2004) 0.83
Radioimmunoassay of ricin A- and B-chains applied to samples of ricin A-chain prepared by chromatofocusing and by DEAE Bio-Gel A chromatography. Biochim Biophys Acta (1982) 0.83
Gel formation and aging in weakly attractive nanocolloid suspensions at intermediate concentrations. J Chem Phys (2011) 0.83
Immunogenicity of three C-terminal synthetic peptides of the beta subunit of human chorionic gonadotropin and properties of the antibodies raised against 45-amino acid C-terminal peptide. J Reprod Immunol (1979) 0.83
Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease. Indian J Ophthalmol (2004) 0.83
Ascites levels of haptoglobin in patients with ovarian cancer. Cancer (1993) 0.83
Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. Cancer (1997) 0.82
Beneficial effect of lysine and amino acids on cataractogenesis in experimental diabetes through possible antiglycation of lens proteins. Exp Eye Res (1998) 0.82
Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol (1996) 0.82
Expression and radiolabeling of recombinant proteins containing a phosphorylation motif. Protein Expr Purif (1996) 0.82
Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J Immunol (1985) 0.82
Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol (1996) 0.82
9,10,19,20-Tetraarylporphycenes. Org Lett (2008) 0.82
High-resolution extracellular stimulation of dispersed hippocampal culture with high-density CMOS multielectrode array based on non-Faradaic electrodes. J Neural Eng (2011) 0.82
Situs inversus with levocardia and congenitally corrected transposition of great vessels with rheumatic tricuspid valve stenosis and regurgitation. Heart Views (2011) 0.82
A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast. Biochem Biophys Res Commun (1995) 0.82
Meso-tetrakis(p-sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy. J Med Chem (2012) 0.81
Persistent left superior vena cava draining into an unroofed coronary sinus in tricuspid atresia: an uncommon anomaly. Pediatr Cardiol (2011) 0.81
Purification and characterization of a new enzyme dipeptidase from human lens. Exp Eye Res (1996) 0.81
Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol (1997) 0.81
Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Clin Exp Metastasis (1995) 0.81
Post transplant thrombotic microangiopathy causing acute renal failure. Indian J Nephrol (2009) 0.81
Childhood systemic lupus erythematosus in south India. Indian J Pediatr (1994) 0.81
[3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation. FEBS Lett (1991) 0.81
Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins. Int J Cancer (2011) 0.81
Ex vivo elimination of lymphoblastic leukemia cells from human marrow by mafosfamid. Leuk Res (1985) 0.81